Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ARMC8 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
mRNA | LINC00633 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
mRNA | ZNF627 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | ZNF266 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | GTF2A1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | USPL1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | INPP5F | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
mRNA | TOB1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | NDUFA1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
mRNA | PACS1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |